Details for 2016823350
Up to date per 01.04.2026
Actions
Details for 2016823350
Granted/Registered
European Patent
31.10.2018 A
28.02.2024 B1
21.12.2015
US
201562270165 P
C12N 15/113 20100101AFI20230904BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
POLYDORO OFENGEIM, ManuelaNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Ave. Cambridge, MA 02139US
WEILER, JanNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Ave. Cambridge, MA 02139US
Information about Fees